结果页面 2，行业：药品制造商 – 仿制药，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (2)
- IOB (17)
- Istanbul (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (8)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (5)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (6)
- Shenzhen (6)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
所有版块
- {{item.name}}
- 所有版块
- 医疗保健 (265)
药品制造商 – 仿制药 (265)
- {{item.name}}
- 所有行业
- 农业投入 (323)
- 建筑材料 (471)
- 化学品 (596)
- 特种化学品 (1365)
- 木材和木材生产 (160)
- 纸和纸制品 (269)
- 铝 (142)
- 铜 (217)
- 其他工业金属和采矿 (2762)
- 金 (1700)
- 银 (83)
- 其他贵金属和采矿 (664)
- 炼焦煤 (72)
- 钢 (743)
- 汽车和卡车经销商 (212)
- 汽车制造商 (390)
- 汽车零部件 (1160)
- 休闲车 (84)
- 家具、固定装置和器具 (509)
- 住宅建筑 (214)
- 纺织品制造 (521)
- 服装制造 (443)
- 鞋类和配件 (206)
- 包装和容器 (482)
- 个人服务 (140)
- 餐厅 (538)
- 服装零售 (289)
- 百货商店 (276)
- 家居装饰零售 (106)
- 奢侈品 (260)
- 互联网零售 (407)
- 专业零售 (547)
- 博彩 (205)
- 休闲 (410)
- 住宿 (323)
- 度假村和赌场 (188)
- 旅行服务 (193)
- 资产管理 (1966)
- 银行 – 多元化 (289)
- 银行 – 区域 (2200)
- 抵押贷款融资 (171)
- 资本市场 (887)
- 金融数据和股票交易所 (152)
- 保险 – 人寿 (247)
- 保险 – 财产和意外伤害 (266)
- 保险 – 再保险 (72)
- 保险 – 专业 (72)
- 保险经纪人 (67)
- 保险 – 多元化 (305)
- 空壳公司 (1821)
- 金融集团 (102)
- 信贷服务 (663)
- 房地产 – 开发 (876)
- 房地产服务 (1138)
- 房地产 – 多元化 (304)
- 房地产投资信托 – 医疗保健设施 (63)
- 房地产投资信托 – 酒店和汽车旅馆 (84)
- 房地产投资信托 – 工业 (140)
- 房地产投资信托 – 办公室 (168)
- 房地产投资信托 – 住宅 (106)
- 房地产投资信托 – 零售 (229)
- 房地产投资信托 – 抵押贷款 (129)
- 房地产投资信托 – 专业 (83)
- 房地产投资信托 – 多元化 (328)
- 酒水 – 啤酒制造商 (154)
- 酒水 – 酒庄和酿酒厂 (234)
- 酒水 – 非酒精类 (213)
- 糖果商 (170)
- 农产品 (608)
- 家用和个人用品 (523)
- 包装食品 (1269)
- 教育和培训服务 (306)
- 折扣店 (96)
- 食品配送 (209)
- 食品杂货店 (233)
- 烟草 (105)
- 生物技术 (2608)
- 药品制造商 – 仿制药 (265)
- 药品制造商 – 特药和仿制药 (1632)
- 医疗保健计划 (57)
- 医疗保健设施 (554)
- 医药零售商 (155)
- 健康信息服务 (419)
- 医疗器械 (916)
- 医疗仪器和用品 (501)
- 诊断和研究 (429)
- 医药分销 (138)
- 公用事业 – 独立发电公司 (150)
- 公用事业 – 可再生能源 (531)
- 公用事业 – 管制水 (166)
- 公用事业 – 管制电 (437)
- 公用事业 – 管制天然气 (197)
- 公用事业 – 多元化 (202)
- 电信服务 (912)
- 广告代理机构 (514)
- 出版 (259)
- 广播 (214)
- 娱乐 (683)
- 互联网内容和信息 (527)
- 电子游戏和多媒体 (485)
- 石油和天然气钻探 (80)
- 石油和天然气勘探与生产 (1187)
- 石油和天然气一体化 (246)
- 石油和天然气中游 (232)
- 石油和天然气精炼与营销 (277)
- 石油和天然气设备与服务 (480)
- 热能煤 (228)
- 铀 (140)
- 航空航天与国防 (566)
- 专业商业服务 (638)
- 咨询服务 (195)
- 出租和租赁服务 (222)
- 安全与保护服务 (266)
- 人事与就业服务 (252)
- 综合性企业 (730)
- 工程与建筑 (1494)
- 基础设施运营 (156)
- 建筑产品和设备 (510)
- 农用和重型工程机械 (377)
- 工业分销 (234)
- 商业设备和用品 (141)
- 特种工业机械 (1714)
- 金属加工 (393)
- 污染与处理控制 (265)
- 工具和配件 (240)
- 电气设备与零件 (895)
- 机场和航空服务 (134)
- 航空公司 (230)
- 铁路 (261)
- 海运 (503)
- 货车运输 (99)
- 综合货运与物流 (389)
- 废物管理 (355)
- 信息技术服务 (1181)
- 软件 – 应用程序 (2025)
- 软件 – 基础设施 (928)
- 通信设备 (732)
- 计算机硬件 (431)
- 消费电子产品 (279)
- 电子元器件 (973)
- 电子和计算机分销 (242)
- 科学技术仪器 (347)
- 半导体设备与材料 (349)
- 半导体 (608)
- 太阳能 (224)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| AbbVie Inc. ABBV.MX | $3,652 216.24 USD |
+3.73
|
$6.45T 381.97B USD | $95 5.63 USD | $3,600.77 213.21 USD | $3,652 216.24 USD | $6.45T 381.97B USD | 81.81 | $44.64 2.64 USD | |
| Johnson & Johnson JNJ.SN | $156.65 — |
0
|
$376.91B — | $0 — | $145.55 — | $145.55 — | $376.91B — | 17.42 | $8.99 — | |
| Novartis AG NVS.BA | $39,275 46.42 USD |
+2.01
|
$309.75T 366.13B USD | $338 0.4 USD | $39,275 46.42 USD | $39,625 46.84 USD | $309.75T 366.13B USD | 2.43 | $16.1K 19.04 USD | |
| Johnson & Johnson JNJ.VI | $135.7 148.34 USD |
+2.18
|
$326.5B 356.91B USD | $15 16.4 USD | $133.22 145.63 USD | $135.7 148.34 USD | $326.5B 356.91B USD | 17.64 | $7.69 8.41 USD | |
| Johnson & Johnson JNJ.DE | $135.58 148.21 USD |
+2.08
|
$326.21B 356.6B USD | $2.5K 2.73K USD | $133.02 145.41 USD | $136.12 148.8 USD | $326.21B 356.6B USD | 17.60 | $7.7 8.42 USD | |
| Johnson & Johnson JNJ.F | $134.72 147.27 USD |
+1.54
|
$324.15B 354.34B USD | $939 1.03K USD | $132.4 144.73 USD | $135.82 148.47 USD | $324.15B 354.34B USD | 17.47 | $7.71 8.43 USD | |
| AstraZeneca PLC AZN.BA | $45,700 54.02 USD |
+3.28
|
$282.69T 334.15B USD | $645 0.76 USD | $45,425 53.69 USD | $45,825 54.17 USD | $282.69T 334.15B USD | 7.28 | $6.27K 7.42 USD | |
| Merck & Co., Inc. MRK.BA | $21,400 25.3 USD |
+4.14
|
$274.58T 324.57B USD | $5.32K 6.29 USD | $21,100 24.94 USD | $21,575 25.5 USD | $274.58T 324.57B USD | 0.24 | $86.83K 102.64 USD | |
| AbbVie Inc. 4AB.F | $168 183.65 USD |
+4.09
|
$296.76B 324.39B USD | $150 163.97 USD | $162 177.09 USD | $168 183.65 USD | $296.76B 324.39B USD | 83.58 | $2.01 2.2 USD | |
| AbbVie Inc. ABBV.VI | $167.2 182.77 USD |
+3.34
|
$295.34B 322.85B USD | $0 0 USD | $162.2 177.31 USD | $167.2 182.77 USD | $295.34B 322.85B USD | 83.18 | $2.01 2.2 USD | |
| AbbVie Inc. 4AB.DE | $167.2 182.77 USD |
+3.47
|
$295.34B 322.85B USD | $288 314.82 USD | $161.8 176.87 USD | $168.4 184.08 USD | $295.34B 322.85B USD | 81.96 | $2.04 2.23 USD | |
| Roche Holding AG ROGN.MX | $6,067 359.24 USD |
0
|
$4.88T 288.8B USD | $0 0 USD | $6,067 359.24 USD | $6,067 359.24 USD | $4.88T 288.8B USD | 25.12 | $241.47 14.3 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Novartis AG N1VS34.SA | $69.41 14.07 USD |
+3.41
|
$1.37T 277.86B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.37T 277.86B USD | 20.00 | $3.47 0.7 USD | |
| Novartis AG NVSN.MX | $2,092.19 123.88 USD |
0
|
$4.51T 266.86B USD | $0 0 USD | $2,092.19 123.88 USD | $2,092.19 123.88 USD | $4.51T 266.86B USD | 17.60 | $118.84 7.04 USD | |
| Roche Holding AG RHHBF | $346.65 — |
+4.1
|
$261.96B — | $1 — | $340 — | $340 — | $261.96B — | 26.80 | $12.93 — | |
| AstraZeneca PLC A1ZN34.SA | $66.46 13.47 USD |
+3.04
|
$1.24T 252.31B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.24T 252.31B USD | 29.93 | $2.22 0.45 USD | |
| AstraZeneca PLC AZNN.MX | $1,341 79.4 USD |
+3.97
|
$4.22T 250.11B USD | $194 11.49 USD | $1,341 79.4 USD | $1,341 79.4 USD | $4.22T 250.11B USD | 28.96 | $46.3 2.74 USD | |
| Merck & Co., Inc. MRCK34.SA | $58.47 11.85 USD |
+0.97
|
$1.21T 244.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.21T 244.84B USD | 13.02 | $4.49 0.91 USD | |
| Roche Holding AG RHO6.F | $34.6 37.82 USD |
+1.99
|
$222.13B 242.82B USD | $92 100.57 USD | $34.46 37.66 USD | $34.6 37.82 USD | $222.13B 242.82B USD | 24.71 | $1.4 1.53 USD | |
| Amgen Inc. AMGN.BA | $12,775 15.1 USD |
+2
|
$204T 241.13B USD | $6.2K 7.33 USD | $12,525 14.8 USD | $12,775 15.1 USD | $204T 241.13B USD | 0.18 | $69.22K 81.83 USD | |
| Merck & Co., Inc. MRK.MX | $1,565.51 92.7 USD |
+0.03
|
$4.05T 239.78B USD | $41.67K 2.47K USD | $1,560 92.37 USD | $1,576.5 93.35 USD | $4.05T 239.78B USD | 12.63 | $123.91 7.34 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Novartis AG NOTA.F | $106 115.87 USD |
+3.92
|
$212B 231.75B USD | $120 131.18 USD | $103 112.59 USD | $106 115.87 USD | $212B 231.75B USD | 19.27 | $5.5 6.01 USD | |
| Merck & Co., Inc. MRK.SN | $83.87 — |
+6.04
|
$222.9B — | $0 — | $0 — | $0 — | $222.9B — | 12.19 | $6.88 — | |
| AstraZeneca PLC AZNCF | $141.4 — |
+0.89
|
$219.2B — | $450 — | $140.15 — | $140.15 — | $219.2B — | 28.50 | $4.96 — | |
| Gilead Sciences, Inc. GILD.BA | $36,375 43 USD |
+4.08
|
$183.91T 217.38B USD | $301 0.36 USD | $36,025 42.58 USD | $36,450 43.09 USD | $183.91T 217.38B USD | 6.05 | $6.01K 7.1 USD | |
| Pfizer Inc. PFE.BA | $8,170 9.66 USD |
+0.86
|
$183.87T 217.33B USD | $16.12K 19.06 USD | $8,110 9.59 USD | $8,280 9.79 USD | $183.87T 217.33B USD | 2.34 | $3.48K 4.12 USD | |
| AstraZeneca PLC ZEGA.F | $61 66.68 USD |
+3.39
|
$190.72B 208.49B USD | $300 327.94 USD | $61 66.68 USD | $61 66.68 USD | $190.72B 208.49B USD | 28.50 | $2.14 2.34 USD | |
| AstraZeneca PLC ZEG.F | $120.05 131.23 USD |
+0.33
|
$188.79B 206.37B USD | $175 191.3 USD | $120.05 131.23 USD | $120.05 131.23 USD | $188.79B 206.37B USD | 28.65 | $4.19 4.58 USD | |
| Merck & Co., Inc. 6MK.F | $72.3 79.03 USD |
+1.12
|
$181.55B 198.46B USD | $2.02K 2.21K USD | $71.3 77.94 USD | $72.5 79.25 USD | $181.55B 198.46B USD | 12.72 | $5.68 6.21 USD | |
| Merck & Co., Inc. MRK.VI | $72.3 79.03 USD |
+1.54
|
$181.55B 198.46B USD | $10 10.93 USD | $71.3 77.94 USD | $72.3 79.03 USD | $181.55B 198.46B USD | 12.57 | $5.75 6.29 USD | |
| Merck & Co., Inc. 6MK.DE | $72.2 78.92 USD |
+1.4
|
$181.3B 198.18B USD | $2.38K 2.6K USD | $71.2 77.83 USD | $72.7 79.47 USD | $181.3B 198.18B USD | 12.51 | $5.77 6.31 USD | |
| Amgen Inc. AMGN34.SA | $59.49 12.06 USD |
+3.39
|
$895.67B 181.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $895.67B 181.54B USD | 27.66 | $2.15 0.44 USD | |
| Amgen Inc. AMGN.MX | $5,436.61 321.91 USD |
-2.04
|
$2.92T 173.1B USD | $9 0.53 USD | $5,436.61 321.91 USD | $5,436.61 321.91 USD | $2.92T 173.1B USD | 26.61 | $204.24 12.09 USD | |
| Pfizer Inc. PFIZ34.SA | $36.04 7.3 USD |
+3.21
|
$820.54B 166.31B USD | $0 0 USD | $0 0 USD | $0 0 USD | $820.54B 166.31B USD | 19.27 | $1.87 0.38 USD | |
| Gilead Sciences, Inc. GILD34.SA | $317.55 64.36 USD |
+3.85
|
$801.18B 162.39B USD | $0 0 USD | $0 0 USD | $0 0 USD | $801.18B 162.39B USD | 24.61 | $12.9 2.61 USD | |
| Pfizer Inc. PFE.MX | $479.94 28.42 USD |
+1.22
|
$2.73T 161.57B USD | $1.06K 62.94 USD | $476 28.19 USD | $483.8 28.65 USD | $2.73T 161.57B USD | 18.60 | $25.8 1.53 USD | |
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1 — | $0 — | $0 — | $157.63B — | 19.38 | $14.84 — | |
| Gilead Sciences, Inc. GILD.MX | $2,100 124.35 USD |
0
|
$2.61T 154.68B USD | $1 0.06 USD | $2,100 124.35 USD | $2,100 124.35 USD | $2.61T 154.68B USD | 23.54 | $89.19 5.28 USD | |
| Amgen Inc. AMGN.VI | $257.8 281.81 USD |
+1.56
|
$138.62B 151.53B USD | $4 4.37 USD | $251.6 275.03 USD | $257.8 281.81 USD | $138.62B 151.53B USD | 27.72 | $9.3 10.17 USD | |
| Amgen Inc. AMG.DE | $257.55 281.54 USD |
+1.7
|
$138.49B 151.38B USD | $443 484.26 USD | $250.9 274.27 USD | $257.55 281.54 USD | $138.49B 151.38B USD | 27.45 | $9.38 10.25 USD | |
| Bristol-Myers Squibb Company BMY.BA | $20,550 24.29 USD |
+3.66
|
$126.12T 149.08B USD | $3.35K 3.96 USD | $20,050 23.7 USD | $20,600 24.35 USD | $126.12T 149.08B USD | 6.07 | $3.38K 4 USD | |
| Amgen Inc. AMG.F | $251.1 274.49 USD |
-0.99
|
$135.02B 147.59B USD | $100 109.31 USD | $251.1 274.49 USD | $251.6 275.03 USD | $135.02B 147.59B USD | 27.17 | $9.24 10.1 USD | |
| Gilead Sciences, Inc. GILD.SN | $110.47 — |
+0.04
|
$140.91B — | $0 — | $110.47 — | $110.47 — | $140.91B — | 23.20 | $4.76 — | |
| Pfizer Inc. PFE.VI | $22.22 24.28 USD |
+2.47
|
$126.3B 138.06B USD | $1.12K 1.23K USD | $21.71 23.73 USD | $22.22 24.28 USD | $126.3B 138.06B USD | 18.66 | $1.19 1.3 USD | |
| Pfizer Inc. PFE.SN | $23.8 — |
-8.67
|
$135.31B — | $0 — | $23.8 — | $23.8 — | $135.31B — | 17.24 | $1.38 — | |
| Pfizer Inc. PFEB.F | $7 7.65 USD |
-0.71
|
$122.7B 134.12B USD | $40 43.73 USD | $7 7.65 USD | $7 7.65 USD | $122.7B 134.12B USD | 17.94 | $0.39 0.43 USD | |
| Gilead Sciences, Inc. GIS.DE | $97.47 106.55 USD |
+1.4
|
$121.25B 132.54B USD | $1.17K 1.27K USD | $95.37 104.25 USD | $97.96 107.08 USD | $121.25B 132.54B USD | 24.00 | $4.06 4.44 USD | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Gilead Sciences, Inc. GILD.VI | $97.46 106.54 USD |
+1.27
|
$121.23B 132.52B USD | $0 0 USD | $96.01 104.95 USD | $97.46 106.54 USD | $121.23B 132.52B USD | 24.12 | $4.04 4.42 USD | |
| Gilead Sciences, Inc. GIS.F | $96.29 105.26 USD |
+0.36
|
$119.78B 130.93B USD | $60 65.59 USD | $96.26 105.23 USD | $96.29 105.26 USD | $119.78B 130.93B USD | 23.89 | $4.03 4.41 USD | |
| GSK plc GSK.BA | $12,625 14.92 USD |
+4.34
|
$102.42T 121.07B USD | $4.92K 5.81 USD | $12,475 14.75 USD | $12,725 15.04 USD | $102.42T 121.07B USD | 19.28 | $654.61 0.77 USD | |
| Sanofi SANO.VI | $84.04 91.87 USD |
+1.12
|
$103.79B 113.46B USD | $39 42.63 USD | $83.65 91.44 USD | $84.04 91.87 USD | $103.79B 113.46B USD | 17.04 | $4.93 5.39 USD | |
| Sanofi SNW2.F | $41.6 45.47 USD |
+0.97
|
$102.89B 112.48B USD | $100 109.31 USD | $41.6 45.47 USD | $41.6 45.47 USD | $102.89B 112.48B USD | 16.77 | $2.48 2.71 USD | |
| Sanofi SNW.F | $84.5 92.37 USD |
+1.28
|
$102.88B 112.46B USD | $754 824.22 USD | $83.31 91.07 USD | $84.5 92.37 USD | $102.88B 112.46B USD | 16.89 | $5 5.47 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $270.42 54.81 USD |
+3.37
|
$550.57B 111.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $550.57B 111.59B USD | 18.66 | $14.49 2.94 USD | |
| Bristol-Myers Squibb Company BMY.MX | $885 52.4 USD |
0
|
$1.81T 106.93B USD | $201 11.9 USD | $885 52.4 USD | $885 52.4 USD | $1.81T 106.93B USD | 17.73 | $49.91 2.96 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $791 46.84 USD |
0
|
$1.6T 94.67B USD | $0 0 USD | $791 46.84 USD | $791 46.84 USD | $1.6T 94.67B USD | 20.53 | $38.52 2.28 USD | |
| Bristol-Myers Squibb Company BRM.F | $41.4 45.26 USD |
+1.88
|
$84.25B 92.1B USD | $472 515.96 USD | $40.81 44.61 USD | $41.51 45.38 USD | $84.25B 92.1B USD | 18.15 | $2.28 2.49 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $41.3 45.15 USD |
+2.11
|
$84.05B 91.88B USD | $0 0 USD | $40.42 44.18 USD | $41.3 45.15 USD | $84.05B 91.88B USD | 18.03 | $2.29 2.5 USD | |
| Bristol-Myers Squibb Company BRM.DE | $41.27 45.11 USD |
+2.14
|
$83.98B 91.8B USD | $349 381.5 USD | $40.36 44.11 USD | $41.58 45.45 USD | $83.98B 91.8B USD | 18.01 | $2.29 2.5 USD | |
| GSK plc G1SK34.SA | $42.38 8.59 USD |
0
|
$433.37B 87.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $433.37B 87.84B USD | 19.09 | $2.22 0.45 USD | |
| GSK GLAXF | $19.85 — |
+2.74
|
$80.25B — | $100 — | $19.31 — | $19.31 — | $80.25B — | 19.08 | $1.04 — | |
| Chugai Pharmaceutical CHGCF | $44.4 — |
-10.52
|
$76.26B — | $200 — | $52 — | $52 — | $76.26B — | 25.96 | $1.71 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $39.61 43.3 USD |
+0.41
|
$68.33B 74.7B USD | $1 1.09 USD | $39.54 43.22 USD | $39.61 43.3 USD | $68.33B 74.7B USD | 26.94 | $1.47 1.61 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $18.36 20.07 USD |
-0.84
|
$35.31B 38.6B USD | $50 54.66 USD | $18.36 20.07 USD | $18.36 20.07 USD | $35.31B 38.6B USD | 20.86 | $0.88 0.96 USD | |
| Bayer Aktiengesellschaft BAYZF | $32.03 — |
+0.91
|
$31.47B — | $2.5K — | $31.1 — | $31.1 — | $31.47B — | 0 | -$3.9 — | |
| Bayer Aktiengesellschaft BAYER.BD | $11,000 30.42 USD |
+0.02
|
$10.81T 29.89B USD | $1.16K 3.2 USD | $10,998 30.42 USD | $11,110 30.73 USD | $10.81T 29.89B USD | 0 | -$1,277 -3.5 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $27.74 30.32 USD |
+1.48
|
$27.25B 29.79B USD | $1.17K 1.28K USD | $27.44 29.99 USD | $27.74 30.32 USD | $27.25B 29.79B USD | 0 | -$3.3 -3.6 USD | |
| Bayer Aktiengesellschaft BAYA.F | $6.7 7.32 USD |
-2.9
|
$27.11B 29.63B USD | $30 32.79 USD | $6.7 7.32 USD | $6.7 7.32 USD | $27.11B 29.63B USD | 0 | -$0.76 -0.8 USD | |
| Biogen Inc. BIIB.BA | $13,250 15.66 USD |
+1.53
|
$24.82T 29.34B USD | $6.25K 7.39 USD | $13,125 15.51 USD | $13,400 15.84 USD | $24.82T 29.34B USD | 1.03 | $12.77K 15.1 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $38.2 41.76 USD |
-2.05
|
$20.56B 22.48B USD | $150 163.97 USD | $38 41.54 USD | $38.8 42.41 USD | $20.56B 22.48B USD | 10.15 | $3.76 4.11 USD | |
| Biogen Inc. BIIB34.SA | $119.16 24.15 USD |
0
|
$106.21B 21.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $106.21B 21.53B USD | 13.02 | $9.15 1.85 USD | |
| Biogen Inc. BIIB.MX | $2,475.32 146.57 USD |
0
|
$362.7B 21.48B USD | $2 0.12 USD | $2,475.32 146.57 USD | $2,475.32 146.57 USD | $362.7B 21.48B USD | 12.83 | $192.88 11.42 USD | |
| Biogen Inc. BIIB.VI | $116.35 127.19 USD |
+2.06
|
$17.05B 18.64B USD | $0 0 USD | $113.25 123.8 USD | $116.35 127.19 USD | $17.05B 18.64B USD | 13.45 | $8.65 9.46 USD | |
| Biogen Inc. IDP.DE | $116.1 126.91 USD |
+1.89
|
$17.01B 18.6B USD | $89 97.29 USD | $112.7 123.2 USD | $116.1 126.91 USD | $17.01B 18.6B USD | 13.37 | $8.68 9.49 USD | |
| Biogen Inc. IDP.F | $114.95 125.66 USD |
+0.79
|
$16.84B 18.41B USD | $25 27.33 USD | $112.55 123.03 USD | $114.95 125.66 USD | $16.84B 18.41B USD | 13.55 | $8.48 9.27 USD | |
| Astellas Pharma ALPMF | $9.46 — |
+0.96
|
$16.94B — | $100 — | $10.1 — | $10.1 — | $16.94B — | 49.78 | $0.19 — | |
| Astellas Pharma Inc. YPHA.F | $7.75 8.47 USD |
0
|
$14.53B 15.89B USD | $26 28.42 USD | $7.75 8.47 USD | $7.75 8.47 USD | $14.53B 15.89B USD | 48.43 | $0.16 0.17 USD | |
| Astellas Pharma Inc. YPH.F | $7.85 8.58 USD |
-0.28
|
$14.44B 15.78B USD | $100 109.31 USD | $7.85 8.58 USD | $7.92 8.66 USD | $14.44B 15.78B USD | 49.05 | $0.16 0.17 USD | |
| Cipla Limited CIPLA.BO | $1,477.3 17.87 USD |
-0.97
|
$1.21T 14.62B USD | $243.29K 2.94K USD | $1,463.1 17.7 USD | $1,491.45 18.04 USD | $1.21T 14.62B USD | 22.66 | $65.19 0.79 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $54.15 59.19 USD |
+1.31
|
$11.33B 12.39B USD | $30 32.79 USD | $54.05 59.08 USD | $54.15 59.19 USD | $11.33B 12.39B USD | 27.21 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $54.3 59.36 USD |
+1.31
|
$11.32B 12.37B USD | $0 0 USD | $54.2 59.25 USD | $54.3 59.36 USD | $11.32B 12.37B USD | 27.28 | $1.99 2.18 USD | |
| CSPC Pharmaceutical CHJTF | $1.05 — |
0
|
$11.99B — | $19.71K — | $1.05 — | $1.05 — | $11.99B — | 20.99 | $0.05 — | |
| CSPC Pharmaceutical CSPCY | $4.12 — |
+2.11
|
$11.77B — | $10K — | $4.12 — | $4.12 — | $11.77B — | 19.61 | $0.21 — | |
| Orion Oyj ORINY | $39.39 — |
+2.66
|
$11.27B — | $162 — | $38.37 — | $39.39 — | $11.27B — | 26.97 | $1.46 — | |
| CSPC Pharmaceutical Group Limited CVGU.F | $3.28 3.59 USD |
0
|
$10.11B 11.05B USD | $4.69K 5.12K USD | $3.28 3.59 USD | $3.28 3.59 USD | $10.11B 11.05B USD | 19.29 | $0.17 0.19 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.8599 0.94 USD |
-2.95
|
$10.1B 11.04B USD | $1.5K 1.64K USD | $0.8599 0.94 USD | $0.8599 0.94 USD | $10.1B 11.04B USD | 21.57 | $0.04 0.04 USD | |
| Orion Oyj OFK0.F | $32.8 35.85 USD |
0
|
$9.24B 10.1B USD | $0 0 USD | $32.8 35.85 USD | $32.8 35.85 USD | $9.24B 10.1B USD | 27.56 | $1.19 1.3 USD | |
| Orion Oyj OFK.F | $66.65 72.86 USD |
+1.14
|
$9.04B 9.88B USD | $15 16.4 USD | $65.7 71.82 USD | $66.65 72.86 USD | $9.04B 9.88B USD | 26.98 | $2.47 2.7 USD | |
| Kyowa Kirin KYKOF | $14.95 — |
0
|
$8.94B — | $63 — | $16.75 — | $16.75 — | $8.94B — | 22.31 | $0.67 — | |
| Abbott India Limited ABBOTINDIA.BO | $34,611.1 418.74 USD |
+0.76
|
$737.8B 8.93B USD | $117 1.42 USD | $34,130 412.92 USD | $34,699.9 419.81 USD | $737.8B 8.93B USD | 51.93 | $666.4 8.06 USD | |
| Abbott India Limited ABBOTINDIA.NS | $34,555 418.06 USD |
+0.48
|
$735.75B 8.9B USD | $4.4K 53.21 USD | $34,125 412.86 USD | $34,845 421.57 USD | $735.75B 8.9B USD | 51.79 | $667.17 8.07 USD | |
| Kyowa Kirin Co., Ltd. KY4.F | $14.4 15.74 USD |
-0.69
|
$7.7B 8.42B USD | $30 32.79 USD | $14.3 15.63 USD | $14.4 15.74 USD | $7.7B 8.42B USD | 25.71 | $0.56 0.61 USD | |
| Grifols, S.A. GIFOF | $8.82 — |
0
|
$8.13B — | $4.41K — | $8.18 — | $8.25 — | $8.13B — | 32.64 | $0.27 — | |
| Grifols GIFLF | $11.45 — |
0
|
$8.13B — | $1.33K — | $10.95 — | $10.95 — | $8.13B — | 42.40 | $0.27 — | |
| Grifols, S.A. GIKLY | $6.7 — |
+9.12
|
$8.13B — | $8K — | $6.64 — | $6.7 — | $8.13B — | 51.53 | $0.13 — | |
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
||||||||||
- {{ link.label }} {{link}}